Cancer, 
July 
1, 
2007 


CANCER 


INSTRUCTIONS 
FOR 
AUTHORS 


For 
the 
most 
up-to-date 
version 
of 
the 
instructions 
and 
for 
Supplements: 
Policy 
and 
Instructions, 
please 
visit 
the 
CANCER 
Web 
site 
at 
http://www.interscience.wiley.com/cancer. 


NEW 
ADDRESS 


Please 
note: 
All correspondence for the journal should be 
sent to the following address. Please include the manuscript-
number with all correspondence (example: C-0000-07): 

CANCER 
Editorial 
Office 
American 
Cancer 
Society 
250 
Williams 
Street 
Atlanta, 
GA 
30303-1002 
Phone: 
(404) 
327-6411 
FAX: 
(404) 
551-5650 
E-mail: 
canceredoff@cancer.org 


Mission 
and 
Scope 
of 
the 
American 
Cancer 
Society 
and 
CANCER: The National Board of Directors of the American Cancer 
Society adopted the following mission statement November 
9, 1994: ‘‘The American Cancer Society is the nationwide community-
based voluntary health organization dedicated to eliminating 
cancer as a major health problem by preventing cancer, 
saving lives and diminishing suffering from cancer through research, 
education, advocacy, and service.’’ CANCER 
is a peer-
reviewed publication of the American Cancer Society integrating 
scientific information from worldwide sources for all oncologic 
specialties. The objective of CANCER 
is to provide an interdisciplinary 
forum for the exchange of clinically applicable information 
among oncologic disciplines concerned with the etiology 
and course of human cancer. CANCER 
accomplishes this objective 
by publishing original articles, as well as other scientific and 
educational documents, that support the mission of the American 
Cancer Society by facilitating the transfer of knowledge from 
the laboratory to the bedside; contributing to cancer prevention, 
early detection, diagnosis, cure, and rehabilitation; and diminishing 
suffering from cancer. 

MANUSCRIPT 
TYPES 
AND 
LENGTH 
LIMITATIONS 
Length 
Limitations 


Papers that grossly exceed the length limitations as described 
in this guide will not be considered for review. 

. 
Original 
Articles: 
Scientific reports of the results of original 
clinical research. The text is limited to 6000 words including 
the title page, abstract, text, references, figures, figure legends, 
and tables. Abstracts are limited to 250 words. 
. 
Accelerated 
Publications: 
A concise and timely presentation 
of significant data. The text should not exceed 2400 words 
with no more than 20 references and a total of four figures 
and tables. Expedited peer review and publication is rare 
and subject to approval by the Editor-in-Chief. 
. 
Book 
Reviews: 
Reviews of selected books in oncologic medicine 
and surgery. Book reviews are generally solicited by the 
Editor-in-Chief. 
. 
Review 
Articles: 
A timely, in-depth treatment of an issue. 
Review articles are generally solicited by the editors, but 
unsolicited materials will be considered. Review articles 
must be no longer than 8000 words including title page, 
abstract,text, tables,figures, figure legends,and references. 
. 
Editorials: 
Opinions of recognized leaders in oncologic specialties. 
Editorials are generally solicited by the Editor-in-
Chief and are related to a manuscript in the same issue. 
Length should not exceed 2400 words with no more than 20 
references. 
. 
Commentaries: 
Presents a point of view of general interest 
not related to an article in the same issue of CANCER. 
. 
Communications: 
Brief notes on selected topics from organizations 
such as the American Cancer Society, the Commission 
on Cancer of the American College of Surgeons, and the 
American Joint Committee on Cancer. 
. 
In 
Memoriam: 
Highlights the accomplishments of distinguished 
individuals who are deceased for their contributions 
to oncology. 
. 
Correspondence: 
Commentaries related to papers previously 
published in CANCER. 
Letters must be submitted within 
three months of the online publication date of the article 
discussed in order to be considered. The authors of the original 
publication will be given the opportunity to respond in 
the same issue of CANCER. Letters and responses must not 
exceed 400 words in length, must be limited to three authors 
and five references, and should not have tables or figures. 
Financial associations or other potential conflicts of interest 
must be disclosed. 
. 
Case 
reports 
of 
single 
cases 
will 
not 
be 
considered. 
Revised 4/07 

A1
Interdisciplinary 
International 
Journal 
of 
the 
American 
Cancer 
Society


A2A2
Interdisciplinary 
International 
Journal 
of 
the 
American 
Cancer 
Society 


MANUSCRIPT 
SUBMISSION 
REQUIREMENTS 
Electronic 
submission 


All manuscripts must 
be submitted electronically using the 
Cadmus Rapid Review System available at http://www.rapidreview. 
com. Manuscripts 
may 
not 
be 
submitted 
by 
E-mail. 
Submit 
text files only as .DOC or .RTF file formats. DOCX and other file 
formats are not permitted and should be converted to DOC. In 
addition to submitting online, authors are required to mail, 
e-mail, or FAX the following to the CANCER 
Editorial Office: 
the ‘‘Authorship Responsibility, Financial Disclosure, and Copyright 
Transfer’’ form signed by all authors; any permissions that 
may have been obtained for figures or tables; any permissions 
required for patient consent. Please 
include 
the 
permanent 
manuscript 
number 
on 
all 
correspondence. 


The following items are required to be included with the 
online submission: 

. 
Cover letter that includes the statement ‘‘All authors have 
read and approved the manuscript’’ as well as any additional 
information that may impact the review process 
. 
Manuscript category (e.g., Editorial, Review Article, Original 
Article, etc.) 
. 
The anatomic site or general topic best suited for the original 
article 
. 
Reviewer suggestions that include names, addresses, phone/ 
FAX numbers, and E-mail addresses 
. 
Corresponding author’s complete contact information to 
include address, phone/FAX numbers, and E-mail address. 
Any changes to this information must be sent immediately 
to the CANCER 
Editorial Office and be updated at http:// 
www.rapidreview.com 
. 
Informed 
consent: 
A statement is required with any report 
of investigations involving human subjects confirming that 
informed consent was obtained from the subject(s) and/or 
guardian(s). Provide this statement in the cover letter and state 
clearly in the manuscript that informed consent was obtained. 
. 
Clinical 
Trial 
Registry: 
Cancer 
now requires that all prospective, 
randomized, controlled trials with patient enrollment 
starting on or after August 1, 2007, be registered in a public 
database that meets the requirements of the World Health 
Organization. Currently, such registries include the following: 
www.actr.org.au, www.clinicaltrials.gov, www.ISRCTN.org, www. 
umin.ac.jp/ctr/index/htm, and www.trialregister.nl. For more 
information, please refer to the guidelines at http://www. 
icmje.org/#clin_trials. Upon submission, please provide the 
registration identification number and the URL for the trial’s 
registry in your cover letter. 
MANUSCRIPT 
COMPONENTS 
General 
Style 


Prepare the manuscript using American spelling and grammar. 
Use the following sources as guidelines for manuscript preparation 
and style: 

. 
Matters of spelling, capitalization, punctuation, hyphenation, 
reference format, and general style: American 
Medical 
Association 
Manual 
of 
Style, 
9th 
ed.1 
. 
Citing cancer stages: American 
Joint 
Committee 
on 
Cancer 
Staging 
Manual,6th ed.2 or UICC 
TNM 
Classification 
of 
Malignant 
Tumours3 
. 
Histologic classification of tumors: World 
Health 
Organization 
International 
Histological 
Classification 
of 
Tumours4 
. 
Drug naming: USP 
Dictionary 
of 
USAN 
and 
International 
Drug 
Names, 
19975 
. 
Chemical terms: Naming 
and 
Indexing 
of 
Chemical 
Substances 
for 
Chemical 
Abstracts6 
. 
Terms relating to diseases, operations, and procedures: 
ICD-O: 
International 
Classification 
of 
Diseases 
for 
Oncology, 
2nd 

ed.,7 Physicians’ 
Current 
Procedural 
Terminology: 
CPT, 
1995,8 and SNOMED 
International9 

. 
Presenting statistical material: Cancer 
Treatment 
Reports10 
. 
Abbreviating journal titles in references: Index 
Medicus11 
. 
Units of measure: Syste´me International (SI) or metric 
system. 
Manuscript 
Format 


The following components are required for a complete manuscript: 
cover letter, title page, abstract, text, references, figure 
legends, publication quality figures, and tables. Include page 
numbers on the document, beginning with the title page as 
number 1. Please use standard 10-or 12-point font size. 

Title 
page 


The following items are required on the title page: 

. 
Manuscript title 
. 
Running title: a short version of the title (up to 40 characters 
including spaces) 
. 
Each author’s name, academic degrees, and affiliation 
. 
Complete mailing address, telephone, facsimile, and E-mail 
for correspondence and reprints 
. 
Total number of each: 1) text pages, including title page, 
references, and figure legends; 2) tables; and 3) illustrations 
. 
Sources of support that require acknowledgment and/ 
or financial disclosure statements (including NIH grant 
numbers) 
. 
Condensed abstract for use in the Table of Contents: two 
concise sentences that state the significant conclusion(s) or 
message of the manuscript (not required for In Memoriam 
or Correspondence) 
. 
Abstract: Original and Review Articles must 
contain an abstract 
of approximately 250 words. Abstracts for Original Articles 
must have four specified subtitles: Background, Methods, 
Results, and Conclusion(s). Abstracts are not required for In 
Memoriam, Editorials, Commentaries, Communications, or 
Correspondence. Abstracts published in CANCER 
are submitted 
to the International Cancer Research Data Bank 
(ICRDB), supported by the National Cancer Institute. This facilitates 
broad circulation of cancer-related abstracts. If the 
ICRDB edits an abstract significantly, it is indicated by a notation 
‘‘modified.’’ Authors are hereby made aware of this procedure 
in advance of submitting a manuscript to CANCER. 
. 
Keywords: 4 to 10 key words or terms to be used as index 
terms. Use terms from the medical subject headings list of 
Index 
Medicus.11 

Drugs 


Use generic name (or generic name followed by trade name in 
parentheses), manufacturer and their location (city and country). 



A3A3
Abbreviations 


Use only standard abbreviations and spell out all abbreviations at 
first use in the text followed by the abbreviation in parentheses.1 

Appendices 


Supplemental materials presented as appendices are not permitted. 
These materials must either be placed within the 
manuscript or eliminated. 

Classification 
and 
staging 


AJCC/UICC TNM Classification and Stage groupings are to be 
used. If another staging system is stated, the AJCC/UICC TNM 
equivalent must also be given.2,3 The stage grouping is a combination 
of the individual T, N, M classifications (e.g., Breast Carcinoma 
Stage IIA is T2 N0 M0. Please note IIA is the stage. T2 N0 M0 
is a combination of T, N, M classifications that satisfy the criteria 
for Stage IIA.). Reference to any T, N, M component is a classification 
and not a stage (e.g., the T2 classification); it is not correct to 
state the classification as a stage (e.g., the T2 stage). When a stage 
or classification is used in the manuscript, a reference citing the 
staging system must be provided. The first time a stage is used it 
must be accompanied by the T, N, M and the verbal translation of 
the numerical identifier (e.g., Breast Carcinoma Stage IIA [T2 N0 
M0]): tumor more than 2 cm but not more than 5 cm in greatest 
dimension [T2], no regional lymph node metastasis [N0], no distant 
metastasis [M0]). 

Statistical 
analysis 


The following guidelines should be followed including statistical 
analyses: 

. 
Report the sample size n 
for each study and each analysis 
. 
Describe the power analysis to justify the sample size if 
appropriate 
. 
Identify all statistical methods and verify the assumptions 
for all statistical tests 
. 
Provide alpha (the probability of a Type I error) for all statistical 
tests 
. 
Specify whether tests are one-or two-sided 
. 
Report the descriptive statistics (n, mean, median, and standard 
deviation) for all continuous variables 
. 
Report n 
and the sample proportion for binary variables 
. 
Adequately explain complex statistical procedures such as multivariate 
logistic regression and the Cox proportional hazard regression 
model and verify the assumptions of each such procedure 
. 
Report the actual P-values and explain what is meant by statistical 
significance 
. 
Discuss and describe adjustments for multiple testing 
References 
If using EndNote (recommended), the CANCER 
reference style can 
be downloaded at www.interscience.wiley.com/jendnotes/. For 
assistance using EndNote, contact endnote@isiresearchsoft.com 
or visit www.endnote.com/support. 
Format. 
Submit references per the following instructions: 

. 
List references double-spaced in a separate reference section 
immediately following the text. 
. 
Verify all references prior to submission. 
. 
Use the American 
Medical 
Association 
Manual 
of 
Style, 
9th 
ed.1 
for reference format style and Index 
Medicus11 for standard 
journal abbreviations (examples to follow). 
. 
Number references sequentially in the order cited in the text; 
do not alphabetize. Remove automatic numbering and linked 
citations; number references manually. 
. 
Do not cite personal communication, unpublished observations, 
and submitted manuscripts. Reference to a paper 
accepted but not yet published can be listed as ‘‘in press.’’ 
‘‘In press’’ references must be updated by the authors as 
soon as publication data are available. 
. 
Provide names of all authors in a reference when there are 
six or fewer; if there are seven or more authors, list only the 
first three, followed by ‘‘et al.’’ 
Reference 
types. 
Following are requirements and examples for 
common reference types: 

. 
Journal 
references 
include the specified information listed 
in the following order—authors, article title and subtitle, 
journal abbreviation, year, volume number in Arabic numerals, 
and inclusive pages. 
Example: 
1. Cohn KH, Ornstein DL, Wang F, et al. The significance 
of allelic deletions and aneuploidy in colorectal carcinoma: 
results of a 5-year follow-up study. Cancer. 1997;79: 233–244. 

. 
Book 
references 
include the following: authors, title, edition (if 
other than the first), volume (if more than one), city, publisher, 
and year. When referencing a book 
chapter, the order 
changes as follows: authors of the chapter, title of the chapter, 
‘‘In:’’, editors/authors of the book, title of the book, edition 
(if there are more than one), volume (if there are more than one), 
city, publisher, year, and inclusive pages of the chapter. 
Example: 
2. Givan AL. Flow 
Cytometry: 
First 
Principles. 
2nd ed. 
New York: John Wiley & Sons, Inc., 2001. 
Example: 
3. Luketich JD, Ginsberg RJ. Diagnosis and staging 
of lung cancer. In: Johnson BE, Johnson DH, editors. Lung 
Cancer. 
New York: Wiley-Liss, Inc., 1995:161–173. 


. 
Electronic 
sources 
should include the type of medium (such 
as ‘‘computer program’’ or ‘‘CD-ROM’’), the version used, and 
the supplier. References to online 
sources 
should include the 
type of medium (such as ‘‘serial online’’ or ‘‘monograph online’’), 
the date of that specific reference (if applicable), the uniform 
resource locator (URL), and the date that the source was 
accessed. For web pages, please include the name of the page 
referenced. A source accessed online should always be referenced 
accordingly, even if it is also published in printed form. 
Example: 
4. Nakamura S, YaoT,AoyagiK,IkdaM, FujishimaM, 
Tsuneyoshi M. Helicobacter pylori and primary gastric lymphoma: 
a histopathologic and immunochemical analysis of 237 
patients. Cancer 
[serial online] 1997;79:3–11. Available from URL: 
http://www.interscience.wiley.com/cancer [accessed Dec 1, 1998]. 
Example: 
5. American Cancer Society. Cancer reference information. 
Available from URL: http://www.cancer.org/docr007/ 
CRI/CRI_0.asp[accessed January 26, 2006]. 

Authors 
are 
responsible 
for 
the 
accuracy 
and 
completeness 
of 
their 
references 
and 
for 
correct 
text 
citation. 


Tables 


. 
Submit single-spaced on separate pages in the word processing 
program used. Tables imported into the word-processing 
program from spreadsheet programs (e.g., Microsoft 
Excel) should be left in table format and not converted to 
text. Gridlines should be retained. 
Interdisciplinary 
International 
Journal 
of 
the 
American 
Cancer 
Society


A4A4
Interdisciplinary 
International 
Journal 
of 
the 
American 
Cancer 
Society 


. 
Do not embed tables as graphic files. They cannot be edited 
by the publisher. 
. 
Limit tables to those that adequately and concisely present 
findings without redundancy. 
. 
Cite all tables in the text. Number tables consecutively, using 
Arabic numerals, in the order cited in the text. The table 
number is followed by a brief descriptive title. 
. 
Include table number, ‘‘continued,’’ and table subheadings 
on each page if a table exceeds one manuscript page. 
. 
Define all abbreviations used in the table in footnotes to the 
table. 
. 
Obtain written permission to reproduce previously published 
tabular material. Credits for the reproduced work are included 
as a footnote to the table and must include author(s), title, either 
publisher and city (and country, if other than US) or periodical 
name, volume, page, and year. Signed permission forms must 
be sent to the CANCER 
Editorial Office upon submissions. 
Figures 
and 
legends 


. 
Submit only publication quality figures in TIFF or EPS file 
format. 
. 
Call out all figures in the text. Number all figures sequentially 
with Arabic numerals in the order cited in the text. 
. 
Provide double-spaced legends on a separate page to include 
the figure number and a brief description of the figure. 
. 
Figures with multiple parts should be labeled and referred to 
as (a), (b), (c), etc. 
. 
Obtain written permission to reproduce previously published 
figures. Credits for the reproduced work are included in the 
figure legend and must include author(s), title, either publisher 
and city (and country, if other than US) or periodical name, 
volume, page, and year. Signed permission forms must be sent 
to the CANCER 
Editorial Office upon submissions. 
Digital 
figures. 
To ensure that your figures are suitable for 
print purposes, please go to RapidInspectorTM at URL: http:// 
rapidinspector.cadmus.com/wi/index.jsp. This free, stand-alone 
software application will help you inspect and verify figures. 

. 
Submit photographs and line art only as TIFF or EPS file formats. 
JPEG or GIF files are not permitted. 
. 
Do not embed figures in word processing programs (e.g., 
Microsoft Word). 
. 
Mask any patient identification in photographs; otherwise, a 
signed permission statement is required (please see Permissions 
section). 
Note: Color figures are published in print and online free of 
charge at the discretion of the editor. 

AUTHORS’ 
PROFESSIONAL 
AND 
ETHICAL 
RESPONSIBILITIES 


Should possible scientific misconduct or dishonesty in research 
submitted for review be suspected or alleged, CANCER 
reserves 
the right to forward any submitted manuscript to the sponsoring 
or funding institution or to other appropriate authorities for investigation. 
CANCER 
recognizes the responsibility to ensure that the 
question is appropriately pursued, but does not undertake the 
actual investigation or make determinations of misconduct. The 
author will be notified if CANCER 
forwards any manuscript or 
materials to the sponsoring or funding institution. 

Authorship 


Authorship 
responsibility, 
financial 
disclosure, 
and 
copyright 
transfer 


Each author should have participated sufficiently in the work 
to take public responsibility for the content. Authorship credit 
should be based only on substantial contributions to 1) Conception 
and design, or analysis and interpretation of data; 2) 
Drafting the article or revising it critically for important intellectual 
content; and 3) Final approval of the version to be published. 
All three conditions must be met.12 Carefully review 
author status prior to submitting a manuscript. Changes to the 
author list (deletions and additions) may not be permitted once 
a manuscript is in review. Each author must read and sign the 
statements on: 

1. Authorship responsibility, criteria, and contributions 
2. Financial disclosure 
3. Either copyright transfer or US Government employment. 
The corresponding author is responsible for collecting the signatures 
of all authors. The signed forms must be sent to the 
CANCER 
Editorial Office upon manuscript submission. 
The 
number 
of 
authors 
on 
a 
manuscript 
should 
not 
exceed 
10. 
Manuscripts 
exceeding 
this 
limit 
will 
be 
returned 
without 
review. 
However, group authorship may be used in 
any of the following three formats as appropriate: 

1. Authorship may be attributed to an entire group (e.g., 
Pediatric Oncology Group) when all members of the group meet 
the criteria for authorship previously outlined. In this case, the 
name of the group is located on the title page in the place of 
authors; each member of the group is listed in a footnote and 
his/her authorship acknowledged. Each member of the group 
must sign the ‘‘Authorship Responsibility, Financial Disclosure, 
and Copyright Transfer’’ form. 
2. The names of up to 10 authors may be listed on the 
title page, followed by the name of the group (e.g., Jane E. Doe, 
John L. Smith, Mark F. Jones, and the Pediatric Oncology 
Group) when the individual authors, as well as all members of 
the group, meet the criteria for authorship previously outlined. 
In this case, group members are listed in a footnote and their 
authorship acknowledged. Each member of the group must 
sign the ‘‘Authorship Responsibility, Financial Disclosure, and 
Copyright Transfer’’ form. 
3. When specified authors assume responsibility for an 
entire group (e.g., Jane E. Doe, John L. Smith, Mark F. Jones for 
the Pediatric Oncology Group), only the specified authors must 
meet the criteria for authorship previously outlined. All members 
of the group may be listed in a footnote but are not acknowledged 
as authors. In this case, the corresponding author must state in 
the cover letter that she/he has written permission from each 
group member to list her/his name as a member of the group. 
CANCER’s 
‘‘Authorship 
Responsibility, 
Financial 
Disclosure, 
and 
Copyright 
Transfer’’ 
form is available online at 
http://www.interscience.wiley.com/cancer. Signatures of every 
author are required. Please include the manuscript number on 
the form. 

Simultaneous 
submission 
and 
online 
posting 
CANCER 
will not consider papers that are simultaneously submitted 
elsewhere or have been published (to include online). If 
a manuscript is posted to an author’s Web site (or their institution’s 
site), it must be taken down prior to submission. Manuscripts 
cannot be posted online until after the paper has been 


A5A5
published in CANCER 
and only if permission has been granted 
by the publisher and the article properly cited. 

Permissions 
Use 
of 
previously 
published 
or 
copyrighted 
material. 
Information 
reproduced from another source must be properly cited. The 
corresponding author is responsible for obtaining written permission 
from the appropriate authors and/or copyright holders to 
use previously published or copyrighted material. Signed permission 
statements from the copyright holder for both print and 
online reproduction must be sent to the CANCER 
Editorial Office 
upon manuscript submission. Permission statements also must 
be obtained from at least one author when citing unpublished 
data, in press articles, and/or personal communications. Permission 
forms may be obtained by contacting the CANCER 
Editorial 
Office or online at www.interscience.wiley.com/cancer. 
Photographs 
with 
identifiable 
patients. 
In photographs, sonograms, 
CT scans, etc., the physical identification of a patient 
should be masked whenever possible. If a patient is identifiable, 
written permission to use the photograph must be obtained 
from the patient or guardian and sent to the CANCER 
Editorial 
Office upon manuscript submission. Clearly state in the manuscript 
that informed consent has been obtained. 

Randomized 
controlled 
trials 


Reports of Randomized Controlled Trials (RCTs) must state 
explicitly how the comparison groups were generated, so that 
readers will be able to assess the method of randomization. In 
the title, pre´cis, and abstract, specify that the manuscript is a 
report of an RCT. Prior to submitting an RCT manuscript, 
authors should refer to the CONSORT checklist.13 

Reports 
of 
Diagnostic 
Tests 


Authors of reports of diagnostic tests are encouraged to submit 
the STARD flow diagram and checklist.14 

PRODUCTION 
Proofs 
to 
Authors 


Page proofs for accepted manuscripts are sent via e-mail to the 
corresponding author from the Publisher, John Wiley & Sons, 
Inc. The corresponding author must return all proof corrections 
within 48 hours and limit changes to corrections of typographical 
errors and errors in the presentation of data. Correspondence 
regarding proofs should be directed to CANCER 
Production Editor, John Wiley & Sons, Inc., 111 River St., Hoboken, 
NJ 07030-5774, USA. Telephone: (201) 748-8870; Facsimile: (201) 
748-6825; E-mail: cncrprod@wiley.com 

Reprints 


A form for ordering reprints is forwarded to the corresponding 
author with the page proofs. To request additional forms, contact 
the Reprints Department, John Wiley & Sons, Inc., 111 River 
St., Hoboken, NJ 07030-5774, USA. Telephone: (201) 748-8771; 
Facsimile: (201) 748-6021; E-mail: cwoods@wiley.com. 

Copying 


. 
2007 American Cancer Society. All rights reserved. No part of 
this publication may be reproduced in any form or by any 
means, except as permitted under section 107 or 108 of the 1976 
United States Copyright Act, without either the prior written 
permission of the publisher, or authorization through the 
Copyright Clearance Center (CCC) Transactional Reporting Service, 
provided that the base fee of $10.00 per copy is paid directly 
to CCC, 222 Rosewood Drive, Danvers, MA 01923 USA, ISSN 
0008-543X/07/$10.00. For authorization for other kinds of copying, 
contact Permissions Department, John Wiley & Sons, Inc., 
111 River St., Hoboken, NJ 07030-5774, USA. Telephone: (201) 
748-6011; Facsimile: (201) 748-6008; E-mail: permreq@wiley. 
com. 

Communications 
to 
the 
Publisher 


For business inquiries, subscription information, orders, or subscriber 
changes of address, contact John Wiley & Sons, Inc., 111 
River St., Hoboken, NJ 07030-5774, USA; or call (201) 748-6995 
(toll-free 1-800-511-3989); Facsimile: (201) 748-6021; E-mail: 
subinfo@wiley.com. 

REFERENCES 


1. 
American Medical Association Manual of Style: A Guide for 
Authors and Editors. 9th ed. Baltimore: Lippincott Williams 
& Wilkins, 1998. 
2. 
Greene FL, Page DL, Fleming ID, et al, eds. American Joint 
Committee on Cancer Staging Manual. 6th ed. Philadelphia: 
Springer, 2002. 
3. 
Sobin LH, Wittekind Ch., eds. TNM Classification of malignant 
tumors. 5th ed. New York: John Wiley & Sons, Inc., 
1997. 
4. 
World Health Organization. International histological classification 
of tumours. 2nd ed. Geneva: World Health Organization, 
1969–1981; Berlin: Springer-Verlag, 1988–Present. 
5. 
USP Dictionary of USAN and International Drug Names, 
1998. Rockville, MD: U.S. Pharmacopeia, 1997. 
6. 
Chemical Abstracts Services. Naming and indexing of chemical 
substances for chemical abstracts, Appendix IV. 
Columbus, OH: Chemical Abstracts Services, 1997. 
7. 
ICD-O: International classification of diseases for oncology. 
2nd ed. Geneva: World Health Organization, 1990. 
8. 
Physicians’ current procedural terminology: CPT, 1998. Chicago: 
JA Majors Co., 1998. 
9. 
Cote RA, Rothwell DJ, Beckett RS, Palotay JL, eds. SNOMED 
international: the systematized nomenclature of human and 
veterinary medicine. 4 vols. Northfield, IL: College of American 
Pathologists, 1993. 
10. 
National Cancer Institute. Cancer treatment reports. 
Washington, DC: National Cancer Institute, 1985;69:1–3. 
11. 
National Library of Medicine. List of journals indexed in 
index medicus. Washington, DC: US Government Printing 
Office [published annually]. 
12. 
International Committee of Medical Journal Editors. Uniform 
requirements for manuscripts submitted to biomedical 
journals. Ann 
Intern 
Med. 1997;126:36–47. Available 
from: URL: http://www.icmje.org [accessed 18 November 
2003]. 
13. 
Moher D, Schultz KF, Altman D, for the CONSORT Group. 
The CONSORT statement: revised recommendations for 
improving the quality of reports of parallel-group randomized 
trials. JAMA. 2001;285:1987–1991. 
14. 
Bossuyt PM, Reitsma JB, Bruns DF, et al. for the STARD 
Group. Towards complete and accurate reporting of studies 
of diagnostic accuracy: the STARD initiative. Clin 
Chem. 2003; 
49:1–18. Available from URL: http://www.clinchem.org/ 
cgi/content/full/49/1/1/ [accessed Sep 13, 2005]. 
Interdisciplinary 
International 
Journal 
of 
the 
American 
Cancer 
Society


A6A6
Interdisciplinary 
International 
Journal 
of 
the 
American 
Cancer 
Society 


CANCER 


Checklist 
for 
Authors 


Please 
use 
this 
checklist 
to 
ensure 
that 
all 
required 
pieces 
accompany 
your 
submission. 
Failure 
to 
provide 
these 
items 
may 
result 
in 
a 
delay 
of 
review. 


u 
Length limitations: Manuscripts exceeding 
the following length limitations will be returned 
with-out review–Original Articles (6,000 words); 
Review Articles (8,000 words). All elements including 
title page, abstract, text, figures, figure legends, 
tables, and references are included in the word 
count. 

Title 
Page: 


u 
Corresponding author with all contact information 


u 
Names, affiliations, and academic or professional 
degrees of each (no more than 10 permitted) 
author 

u 
Shortened title of no more than 40 characters, 
including spaces 

u 
Manuscript category: Original Article (specify 
an anatomic site or a general topic), Editorial, 
Commentary, Review Article, etc. 

u 
Any acknowledgements 

u 
All financial disclosures, funding considerations 
(including NIH funding), and conflicts of 
interest 

u 
A statement confirming patients’ informed 
consent, if applicable 

u 
A page count along with a count of tables 
and figures 

u 
Condensed 
Abstract: 
two concise sentences 
summarizing all significant findings 

u 
Abstract: 
must contain Background, Methods, 
Results, and Conclusions 

& 
Keywords: 
between 4 and 10 keywords must 
follow the abstract. 

Text 
and 
formatting: 


u 
Double-spaced throughout, ragged right margin, 
and size 10-or 12-point font 

u 
References: 
properly formatted and numbered 


Figures: 


u 
Must appear on separate pages at the end of 
the manuscript 

u 
Must be sequentially numbered and called-
out in the text 

u 
Legends should appear on a page separate 
from the figures themselves 

u 
Should not be embedded in word processing 
documents but rather submitted in TIFF or EPS 
file formats 

u 
Any figures being reproduced from another 
source must have permission and proper credit. 
All signed permissions must be sent to the CANCER 
Editorial Office. 

Tables: 


u 
Submitted single-spaced and in the word 
processing software used. Do not embed tables as 
graphic files, document objects, or pictures. 

u 
Any tables being reproduced from another 
source must have permission and proper credit. 
All signed permissions must be sent to the CANCER 
Editorial Office. 

To 
submit 
a 
manuscript: 


1. Submit manuscript electronically at www. 
rapidreview.com. 
2. Send the following items by mail or facsimile 
[include the manuscript number on all correspondence 
(example: C-0000-07)] to the CANCER 
Editorial Office: 
u 
‘‘Authorship Responsibility, Financial Disclosure, 
and Copyright Transfer’’ form signed by ALL 
of the authors (original signatures required) 

u 
Signed copies of any permissions that may have 
been acquired (figures, tables, patient consent) 

INCOMPLETE 
SUBMISSIONS 
WILL 
BE 
DELAYED 



